|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01470924 |
|
Date of registration:
|
07/11/2011 |
|
Primary sponsor: |
|
|
Public title:
|
Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007
|
|
Scientific title:
|
High Curability Via Intensive Reinduction Chemotherapy and Stem Cell Transplantation in Young Adults With Relapsed Acute Lymphoblastic Leukemia in Sweden 2003-2007 |
|
Date of first enrolment:
|
January 2003 |
|
Target sample size:
|
76 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01470924 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
Sweden
| | | | | | | |
|
Contacts
|
|
Name:
|
Piotr J Kozlowski, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Orebro University Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Adult patients with first relapse of ALL
Exclusion Criteria:
- patients with Burkitt leukemia
Age minimum:
18 Years
Age maximum:
66 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Acute Lymphoblastic Leukemia
|
|
Secondary ID(s)
|
|
OLL-180361
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|